Peter M Elias Selected Research

X-Linked Ichthyosis (Ichthyosis, X Linked)

3/2015	Cellular basis of secondary infections and impaired desquamation in certain inherited ichthyoses.
3/2014	Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis.
5/2012	Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders.
4/2008	Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism.
9/2006	Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Chanarin-Dorfman syndrome).
2/2004	Basis for abnormal desquamation and permeability barrier dysfunction in RXLI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter M Elias Research Topics

Disease

38	Atopic Dermatitis (Atopic Eczema) 01/2022 - 08/2002
35	Inflammation (Inflammations) 06/2022 - 01/2002
15	Skin Diseases (Skin Disease) 01/2022 - 03/2005
14	Ichthyosis (Xeroderma) 01/2021 - 04/2004
10	Pruritus (Itching) 01/2020 - 11/2007
10	Allergic Contact Dermatitis 01/2019 - 01/2002
8	Wounds and Injuries (Trauma) 11/2020 - 04/2005
8	Dermatitis 10/2020 - 01/2002
8	Hyperplasia 11/2009 - 01/2002
6	X-Linked Ichthyosis (Ichthyosis, X Linked) 03/2015 - 02/2004
6	Contact Dermatitis (Eczema, Contact) 02/2013 - 08/2004
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 03/2005
5	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 01/2017 - 09/2005
5	Infections 04/2014 - 11/2007
5	Muscle Cramp (Cramp) 08/2012 - 01/2008
4	Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects 01/2021 - 11/2011
4	Hypersensitivity (Allergy) 01/2020 - 01/2008
4	Eczema 01/2020 - 05/2007
4	Netherton Syndrome 01/2019 - 07/2006
4	Gaucher Disease (Gaucher's Disease) 03/2015 - 09/2006
4	Lamellar Ichthyosis (Harlequin Ichthyosis) 04/2008 - 04/2004
3	Erythema 12/2018 - 01/2016
3	Chanarin-Dorfman Syndrome 03/2015 - 09/2006
2	Dehydration (Water Stress) 12/2021 - 01/2017
2	Neoplasms (Cancer) 01/2019 - 11/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 08/2010
2	Carcinogenesis 01/2013 - 03/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2022
1	Coinfection 12/2021
1	Disease Susceptibility (Diathesis) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Peanut Hypersensitivity (Peanut Allergy) 01/2021
1	Nevus (Nevi) 08/2019

Drug/Important Bio-Agent (IBA)

27	LipidsIBA 02/2022 - 01/2002
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
12	Filaggrin ProteinsIBA 01/2021 - 09/2004
12	Irritants (Vesicants)IBA 12/2019 - 01/2002
11	CytokinesIBA 06/2022 - 01/2002
10	Immunoglobulin E (IgE)IBA 12/2014 - 01/2008
9	EnzymesIBA 01/2021 - 04/2005
9	OxazoloneIBA 10/2020 - 02/2003
8	Antimicrobial PeptidesIBA 01/2020 - 11/2007
7	CeramidesIBA 02/2022 - 08/2002
7	GlucocorticoidsIBA 12/2014 - 01/2002
6	CholesterolIBA 01/2021 - 02/2003
5	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 03/2007
5	HaptensIBA 01/2019 - 01/2008
5	CathelicidinsIBA 08/2012 - 04/2008
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2011 - 03/2006
4	Messenger RNA (mRNA)IBA 01/2021 - 04/2008
4	PPAR alphaIBA 01/2010 - 01/2002
4	Liver X ReceptorsIBA 01/2010 - 01/2002
3	Adenosine Monophosphate (AMP)IBA 06/2012 - 11/2007
3	phorbolIBA 01/2012 - 02/2003
3	Serine Proteases (Serine Protease)IBA 12/2011 - 07/2006
3	PPAR-betaIBA 01/2010 - 03/2006
2	Nonesterified Fatty Acids (NEFA)IBA 02/2022 - 01/2002
2	AllergensIBA 12/2021 - 12/2019
2	Differentiation AntigensIBA 01/2021 - 12/2008
2	Interleukin-4 (Interleukin 4)IBA 10/2020 - 01/2013
2	Melanins (Melanin)IBA 01/2017 - 01/2016
2	cholesteryl sulfateIBA 03/2014 - 04/2008
2	Steryl-Sulfatase (Steroid Sulfatase)IBA 03/2014 - 02/2004
2	ApigeninIBA 03/2013 - 01/2012
2	Lovastatin (Mevacor)FDA LinkGeneric 01/2013 - 05/2012
2	Therapeutic UsesIBA 01/2012 - 11/2011
2	Glucosylceramidase (Glucocerebrosidase)IBA 12/2011 - 04/2008
2	Glucosylceramides (Glucocerebrosides)IBA 12/2011 - 04/2008
2	Phorbol EstersIBA 11/2011 - 08/2008
2	LigandsIBA 11/2011 - 09/2011
2	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2011 - 09/2011
2	PPAR gammaIBA 01/2010 - 08/2004
2	beta-DefensinsIBA 12/2008 - 11/2007
2	loricrinIBA 09/2005 - 04/2004
2	transglutaminase 1IBA 09/2005 - 04/2005
2	SterolsIBA 05/2003 - 02/2003
2	OxysterolsIBA 02/2003 - 01/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 06/2022
1	EmollientsIBA 01/2022
1	Lipoxygenase (Lipoxygenase-1)IBA 01/2021
1	SphingosineIBA 01/2021
1	Sunflower OilIBA 01/2021
1	Urocanic AcidIBA 01/2021
1	Pyrrolidinones (Pyrrolidones)IBA 01/2021
1	NeurotoxinsIBA 01/2021
1	Carboxylic AcidsIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 11/2020
1	allicinIBA 11/2020
1	Interleukin-13IBA 10/2020
1	Interleukin-17 (Interleukin 17)IBA 10/2020
1	Interleukin-5 (Interleukin 5)IBA 10/2020
1	Disinfectants (Biocides)IBA 01/2020
1	ResveratrolIBA 01/2020
1	Plant ExtractsIBA 02/2019
1	HesperidinIBA 01/2019

Therapy/Procedure

19	Therapeutics 01/2022 - 12/2007
3	Skin Care 12/2018 - 06/2013
1	Subcutaneous Injections 10/2020
1	Lasers (Laser) 08/2019